4Basebio PLC
LSE:4BB
Balance Sheet
Balance Sheet Decomposition
4Basebio PLC
4Basebio PLC
Balance Sheet
4Basebio PLC
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
15
|
10
|
4
|
3
|
35
|
|
| Cash |
0
|
15
|
10
|
4
|
3
|
35
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
1
|
1
|
1
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
1
|
16
|
11
|
6
|
5
|
37
|
|
| PP&E Net |
0
|
1
|
3
|
4
|
4
|
4
|
|
| PP&E Gross |
0
|
1
|
3
|
4
|
4
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
2
|
2
|
|
| Intangible Assets |
0
|
1
|
1
|
2
|
3
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
18
+1 442%
|
15
-17%
|
12
-20%
|
12
+2%
|
45
+275%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
2
|
2
|
2
|
3
|
|
| Long-Term Debt |
2
|
1
|
1
|
3
|
10
|
15
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
2
-23%
|
3
+28%
|
5
+52%
|
12
+172%
|
18
+48%
|
|
| Equity | |||||||
| Common Stock |
6
|
11
|
11
|
11
|
11
|
14
|
|
| Retained Earnings |
8
|
3
|
0
|
5
|
12
|
24
|
|
| Additional Paid In Capital |
0
|
1
|
1
|
1
|
1
|
37
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
15
N/A
|
12
-24%
|
7
-39%
|
0
N/A
|
26
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
18
+1 442%
|
15
-17%
|
12
-20%
|
12
+2%
|
45
+275%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
12
|
12
|
12
|
12
|
12
|
15
|
|